Genome-wide analysis of Structural Variants in Parkinson’s Disease

Genome-wide analysis of Structural Variants in Parkinson’s Disease
Ann Neurol. 2023 Jan 25. doi: 10.1002/ana.26608. Online ahead of print.ABSTRACTOBJECTIVE: Identification of genetic risk factors for Parkinson's disease (PD) has to date been primarily limited to the study of single nucleotide variants, which only represent a small fraction of the genetic variation in the human genome. Consequently, causal variants for most PD risk are not known. Here we focused ... read more
Source: PubMedPublished on 2023-01-25By Kimberley J Billingsley